PCN110 PRELIMINARY ANALYSIS OF THE COST-EFFECTIVENESS OF NECITUMUMAB AS FIRST LINE THERAPY IN PATIENTS WITH STAGE IV SQUAMOUS NON SMALL CELL LUNG CANCER IN JAPAN
2019
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI